Jump to content

Methylenedioxyhydroxyethylamphetamine

From Wikipedia, the free encyclopedia
Methylenedioxyhydroxyethyl­amphetamine
Names
Preferred IUPAC name
2-{[(2H-1,3-Benzodioxol-5-yl)propan-2-yl]amino}ethan-1-ol
Other names
3,4-Methylenedioxy-N-hydroxyethylamphetamine
3,4-Methylenedioxy-1-(alpha-methylaminohydroxyethyl)ethane
MDOHET, MDHET, MDHEA
Identifiers
3D model (JSmol)
ChemSpider
UNII
  • InChI=1S/C12H17NO3/c1-9(13-4-5-14)6-10-2-3-11-12(7-10)16-8-15-11/h2-3,7,9,13-14H,4-6,8H2,1H3 ☒N
    Key: SCUUYKMQDUDNBP-UHFFFAOYSA-N ☒N
  • C1=C2C(=CC=C1CC(C)NCCO)OCO2
Properties
C12H17NO3
Molar mass 223.271 g/mol
Except where otherwise noted, data are given for materials in their standard state (at 25 °C [77 °F], 100 kPa).
☒N verify (what is checkY☒N ?)

MDHOET, or 3,4-methylenedioxy-N-hydroxyethylamphetamine, is a lesser-known psychedelic drug and a substituted amphetamine. It is also the N-hydroxyethyl analogue of MDA. MDHOET was first synthesized by Alexander Shulgin. In his book PiHKAL (Phenethylamines i Have Known And Loved), the minimum dosage is listed as 50 mg. MDHOET produces few to no effects. Very little data exists about the pharmacology, pharmacokinetics, effects, and toxicity of MDHOET.

Legality

[edit]

United Kingdom

[edit]

This substance is a Class A drug in the Drugs controlled by the UK Misuse of Drugs Act.[1]

See also

[edit]

References

[edit]
  1. ^ "UK Misuse of Drugs act 2001 Amendment summary". Isomer Design. Retrieved 12 March 2014.
[edit]